| Central Oregon Eyecare, Pc | |
|
1000 Sw Indian Ave, Redmond, OR 97756 | |
| (541) 548-2488 | |
| (541) 548-5334 |
| Full Name | Central Oregon Eyecare, Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1000 Sw Indian Ave, Redmond, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073715157 | NPI | - | NPPES |
| 230762 | Medicaid | OR | |
| U85325 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2823ATI (Oregon) | Primary |
| Provider Name | Todd M Sheldon |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1417980541 PECOS PAC ID: 1850288119 Enrollment ID: I20040317000238 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Provider Name | Toni M Decker |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1932299526 PECOS PAC ID: 4981784139 Enrollment ID: I20071231000367 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Provider Name | Brian C Oulman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1699937813 PECOS PAC ID: 2769557131 Enrollment ID: I20141001000026 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Provider Name | Nicholas J Blight |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1588193791 PECOS PAC ID: 9830468669 Enrollment ID: I20170710002563 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Provider Name | Etosha C Fegan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275996894 PECOS PAC ID: 4981962131 Enrollment ID: I20171218002011 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Provider Name | Kevie E.k. Kawasaki |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1740849199 PECOS PAC ID: 3971839473 Enrollment ID: I20190722001547 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Provider Name | Chelsea N Territo |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1003475625 PECOS PAC ID: 9537495379 Enrollment ID: I20190731002242 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Provider Name | Keiji Jay Shiyomura |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1609527613 PECOS PAC ID: 6709271943 Enrollment ID: I20220324002054 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Provider Name | Taran Lasater |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265662381 PECOS PAC ID: 6305034174 Enrollment ID: I20230621003341 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Central Oregon Eyecare, Pc 1000 Sw Indian Ave, Redmond, OR 97756 Ph: (541) 548-2488 | Central Oregon Eyecare, Pc 1000 Sw Indian Ave, Redmond, OR 97756 Ph: (541) 548-2488 |
News Archive
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.
ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.
The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
› Verified 5 days ago
Bend Memorial Clinic Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 865 Sw Veterans Way, Redmond, OR 97756 Phone: 541-322-3500 | |
Dr. Donald Leon Peterson, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 813 Sw Highland Ave, Redmond, OR 97756 Phone: 541-548-7170 | |
Karisa M Cervantes, OD Optometrist Medicare: Medicare Enrolled Practice Location: 443 Sw Evergreen Ave, Redmond, OR 97756 Phone: 541-923-2221 | |
Dr. Todd Michael Sheldon, OD MBA FAAO Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 Sw Indian Avenue, Redmond, OR 97756 Phone: 541-548-2488 Fax: 541-548-5334 | |
Audrey H Brumley, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 443 Sw Evergreen Ave, Redmond, OR 97756 Phone: 541-923-2221 Fax: 541-923-3776 | |
Mrs. Kilah Shea Atkinson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 443 Sw Evergreen Ave, Redmond, OR 97756 Phone: 541-923-2221 Fax: 541-923-3776 |